Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream

by Ocvirk, Janja
Published 2010

Malignant gliomas: old and new systemic treatment approaches

by Mesti Tanja, Ocvirk Janja
Published 2016-06-01

Malignant gliomas: old and new systemic treatment approaches

by Mesti, Tanja, Ocvirk, Janja
Published 2016

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rect...

by Oblak, Irena, Velenik, Vaneja, Anderluh, Franc, Mozina, Barbara, Ocvirk, Janja
Published 2013

A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis

by Ocvirk, Janja, Heeger, Steffen, McCloud, Philip, Hofheinz, Ralf-Dieter
Published 2013

Cetuximab in preoperative treatment of rectal cancer – term outcome of the XERT trial

by Velenik, Vaneja, Ocvirk, Janja, Oblak, Irena, Anderluh, Franc
Published 2012

Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib

by Gavric Ana Ursula, Ocvirk Janja, Mekjavic Polona Jaki
Published 2018-01-01

Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer – a single institution retrospective analysis...

by Rebersek, Martina, Boc, Marko, Cerkovnik, Petra, Benedik, Jernej, Hlebanja, Zvezdana, Volk, Neva, Novakovic, Srdjan, Ocvirk, Janja
Published 2011

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III

by Oblak, Irena, Anderluh, Franc, Velenik, Vaneja, Mozina, Barbara, Ocvirk, Janja, Ciric, Eva, Podvrsnik, Natasa Hrovatic
Published 2011

The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement

by Mesti Tanja, Boshkoska Biljana Mileva, Kos Mitja, Tekavčič Metka, Ocvirk Janja
Published 2015-06-01

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience

by Mesti, Tanja, Moltara, Maja Ebert, Boc, Marko, Rebersek, Martina, Ocvirk, Janja
Published 2015

The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement

by Mesti, Tanja, Boshkoska, Biljana Mileva, Kos, Mitja, Tekavčič, Metka, Ocvirk, Janja
Published 2015

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

by Velenik, Vaneja, Ocvirk, Janja, Music, Maja, Bracko, Matej, Anderluh, Franc, Oblak, Irena, Edhemovic, Ibrahim, Brecelj, Erik, Kropivnik, Mateja, Omejc, Mirko
Published 2011

Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells

by Mesti, Tanja, Savarin, Philippe, Triba, Mohamed N., Le Moyec, Laurence, Ocvirk, Janja, Banissi, Claire, Carpentier, Antoine F.
Published 2014

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience

by Ocvirk Janja, Moltara Maja Ebert, Mesti Tanja, Boc Marko, Rebersek Martina, Volk Neva, Benedik Jernej, Hlebanja Zvezdana
Published 2016-06-01

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience

by Ocvirk, Janja, Moltara, Maja Ebert, Mesti, Tanja, Boc, Marko, Rebersek, Martina, Volk, Neva, Benedik, Jernej, Hlebanja, Zvezdana
Published 2016

Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors

by Hofheinz, Ralf-Dieter, Deplanque, Gaël, Komatsu, Yoshito, Kobayashi, Yoshimitsu, Ocvirk, Janja, Racca, Patrizia, Guenther, Silke, Zhang, Jun, Lacouture, Mario E., Jatoi, Aminah
Published 2016